Siegfried Holding
Siegfried Holding AG is a Swiss contract development and manufacturing organization serving the global pharmaceutical industry. The company provides chemical and biological contract development and manufacturing services, specializing in active pharmaceutical ingredients, intermediates, and sterile dosage formulations. Its operational capabilities encompass chemical synthesis, drug product manufacturing, sterile filling, and analytical development across facilities in Europe, North America, and Asia. Revenue is derived from long-term manufacturing agreements, contract development fees, and commercial supply contracts with global pharmaceutical companies. Siegfried Holding is a leading independent CDMO partner in the global life sciences sector. The company is headquartered in Zofingen, Switzerland, and its shares trade on the SIX Swiss Exchange.
11 of the funds FundTelligence covers report a position in Siegfried Holding.
- Legal name
- Siegfried Holding AG
- Sector
- Health Care
- Country
- Switzerland
- Funds holding it
- 11
Funds holding Siegfried Holding
- Nordea European Small and Mid Cap Sustainable Stars — Nordea Funds · 1.52 % (full portfolio disclosed, July 2026)
- DWS Invest ESG European Small/Mid Cap — DWS · 1.2 % (full portfolio disclosed, June 2026)
- Nordea Global Small Cap — Nordea Funds · 1.06 % (full portfolio disclosed, September 2026)
- Nordea Global Small Cap Enhanced — Nordea Funds · 1.06 % (full portfolio disclosed, September 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.34 % (full portfolio disclosed, October 2026)
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.22 % (full portfolio disclosed, September 2026)
- Handelsbanken Infrastruktur och Beredskap — Handelsbanken · 0.16 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Small Cap — DNB · 0.04 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 11 funds holding it.